| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.097 | 0.04 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |